Antares Pharma (AIS)
Antares Pharma Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -0.0744M | -0.1539M | -1.299M | -1.554M | -1.381M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.0462M | 0.0467M | 0.0446M | 0.0364M | 0.0405M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.5117M | 0.3839M | 0.5797M | 0.4076M | 0.4716M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 0.558M | 0.4305M | 0.6243M | 0.4439M | 0.5122M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -2.000M | 2.135M | -0.6036M | -0.2412M | -0.8388M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -1.516M | 2.411M | -1.279M | -1.351M | -1.707M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.2053M | -0.1227M | -0.0561M | -0.0438M | -0.0979M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -0.0084M | 0.00 | -15.05M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -0.2354M | -0.2004M | -15.15M | -0.1106M | -0.1445M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 0.5829M | 0.0476M | 0.454M | 21.72M | 5.080M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | -0.0289M | 0.00 | -0.2333M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Net Cash from Financing Activities | 0.554M | 0.0476M | 0.2207M | 21.72M | 5.080M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.0071M | -0.0193M | -0.0002M | 0.003M | -0.0095M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -1.190M | 2.239M | -16.21M | 20.26M | 3.219M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 19.36M | 9.848M | 19.36M | 17.12M | 33.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 18.17M | 19.36M | 17.12M | 33.33M | 13.07M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
